ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.

Gulidanna Shayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.